Investigation of breast cancer using two-dimensional MRS

NMR in Biomedicine

Volumn 22, Issue 1, 2009, Pages 77-91

  Thomas, M Albert ^a,b   Lipnick, Scott ^a   Velan, S Sendhil ^c   Liu, Xiaoyu ^a   Banakar, Shida ^a   Binesh, Nader ^a,d   Ramadan, Saadallah ^e   Ambrosio, Art ^a,f   Raylman, Raymond R ^c   Sayre, James ^a   DeBruhl, Nanette ^a   Bassett, Lawrence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Breast cancer; Choline groups; Correlated spectroscopy; J resolved spectroscopy; Magic angle spinning; MRS; Perchloric acid; Saturated and unsaturated lipids

Indexed keywords

BREAST CANCER; CHOLINE GROUPS; CORRELATED SPECTROSCOPY; J-RESOLVED SPECTROSCOPY; MAGIC ANGLE SPINNING; MRS; PERCHLORIC ACID; SATURATED AND UNSATURATED LIPIDS;

FATTY ACIDS; HISTOLOGY; INORGANIC ACIDS; LIPIDS; MAGNETIC FIELDS; METABOLISM; RECONNAISSANCE AIRCRAFT; RESONANCE; TREES (MATHEMATICS); TWO DIMENSIONAL;

MAGNETIC RESONANCE SPECTROSCOPY;

CHOLINE; CREATINE KINASE; ETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; LYSINE; PERCHLORIC ACID; PHOSPHORYLCHOLINE; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

BODY FAT; BODY WATER; BREAST CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER REGRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; INTRADUCTAL CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL NUCLEAR MAGNETIC SPECTROSCOPY;

BREAST NEOPLASMS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHANTOMS, IMAGING; TISSUE EXTRACTS; TRIGLYCERIDES;

EID: 65349110491     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1310     Document Type: Review

References (100)

1. Berman CG. Recent advances in breast specific imaging. Cancer Control. 2007; 14: 338-349.
2. Sabel M, Aichinger H. Recent developments in breast imaging. Phys Med Biol. 1996; 41(3): 315-368.
3. Adler DD, Wahl RL. New methods for imaging breast techniques, findings, and potential. AJR Am J Roentgenol. 1995; 164(1): 19-30.
4. Stelling CB. MR imaging of the breast for cancer evaluation. Current status and future directions. Radiol Clin North Am. 1995; 33(6): 1187-1204.
5. Orang-Khadivi K, Pierce BL, Ollom CM, Floyd LJ, Siegle RL, Williams RF. New magnetic resonance imaging techniques for detection of breast cancer. Breast Cancer Res Treat. 1994; 32(1): 119-135.
6. Weinreb JC, Newstead G. MR imaging of the breast Radiology. 1995; 196(3): 593-610.
7. Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am. 2007; 45: 863-880.
8. Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, Bluemke DA, Bowen DJ, Marcom PK, Armstrong DK, Domchek SM, Tomlinson G, Skates SJ, Gatsonis C. Cancer yield of mammography, MR and US in high-risk women: perspective multi-institution breast cancer screening study. Radiology. 2007; 244: 381-388.
9. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA, American Cancer Society Breast Cancer Advisory Group. American Cancer Society Guidelines for breast screening with MRI as aq adjunct to mammography. CA Cancer J Clin. 2007; 57: 75-89.
10. Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl C, Julian TB, Hylton N, Weatherall P, O'loughlin M, Schnitt SJ, Gatsonis C, Schnall MD. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005; 92: 9-15 discussion 15-16.
11. Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O. Breast lesions: evaluation with dynamic contract-enhanced T1 weighted MR Imaging and with T2* weighted first-pass perfusion MR imaging. Radiology. 2000; 216: 545-553.
12. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology. 1997; 204: 661-666.
13. 1H MRS at 1.5T. Eur Radiol. 2005; 15(5): 1037-1043.
14. Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res. 2005; 7: 149-152.
15. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology. 2004, 232: 585-591.
16. 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology. 2005; 6: 465-475.
17. Jagannathan NR, Singh M, Govindaraju V, Raghunathan P, Coshic O, Julka PK, Rath GK. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed. 1998; 11: 414-422.
18. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK. Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84: 1016-1022.
19. Petroff OA, Rothman DL, Behar KL, Mattson RH. Low brain GABA level is associated with poor seizure control. Ann Neurol. 1996; 40: 908-911.
20. Prichard JW. New nuclear magnetic resonance data in epilepsy. Curr Opin Neurol. 1997; 10: 98-102.
21. Hurd RE, Freeman DM. Metabolic specific proton magnetic resonance imaging. Proc Natl Acad Sci USA. 1989; 86: 4402-4406.
22. Trimble LA, Shen JF, Wilman AH, Allen PS. Lactate editing by means of selective, pulse filtering of both zero and double quantum coherence signals. J Mag Reson. 1990; 86: 191-198.
23. 1H MRS of breast lesions. Magn Reson Med. 2002; 48(2): 215-222.
24. Ernst RR, Bodenhausen G, Wokaun A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Oxford Publications: Oxford, 1987.
25. Thomas MA, Huda A, Chung HK, Binesh N. Spatially resolved two-dimensional MR spectroscopy in vivo. Annual Reports in NMR Spectroscopy: Handbook of Modern Magnetic Resonance, Webb G (ed.). Kluwer Academic Publishers: New York, 2006, 2: 1157-1169.
26. Friebolin H. Basic One- and Two-Dimensional NMR Spectroscopy, 3rd edn. Wiley-VCH Publications: Weinheim, 1998; 231-285.
27. Méric P, Autret G, Doan BT, Gillet B, Sébrié C, Beloeil JC. In vivo 2D magnetic resonance spectroscopy of small animals. MAGMA. 2004; 17: 317-338.
28. Martin GE, Zetker AS. Two-Dimensional NMR Methods for Establishing Molecular Connectivity. VCH Publishers Inc.: New York, 1988.
29. Foster MP, McElroy CA, Amero CD, Solution, Solution NMR of large molecules and assemblies. Biochemistry. 2007, 46: 331-340.
30. Thomas MA, Binesh N, Yue K, DeBruhl N. Volume localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging. 2001; 14: 181-186.
31. Thomas MA, Wyckoff N, Yue K, Binesh N, Banakar S, Chung HK, Sayre J, DeBruhl N. Two-dimensional MR spectroscopic characterization of breast cancer in vivo. Technol Cancer Res Treat. 2005; 4(1): 99-106.
32. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994; 7: 181-194.
33. 1H magnetic resonance spectroscopy: a pilot study. Magn Reson Imaging. 2004; 22: 697-706.
34. May GL, Wright LC, Holmes KT; Williams PG, Smith IC, Wright PE, Fox RM, Mountford CE. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J Biol Chem. 1986, 261: 3048-3053.
35. May GL, Wright LC, Lean CL, Mountford CE. Identification of 1-O-alkyl-2,3-diacyl-sn-glycerol in plasma membranes of cancer cells. J Magn Reson. 1992; 98: 622-627.
36. Mountford CE, Lean CL, Hancock R, Dowd S, Mackinnon WB, Tattersall MH, Russell P. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion Metastasis. 1993; 13: 57-71.
37. Le Moyec L, Tatoud R, Eugène M, Gauvillé C, Primot I, Charlemagne D, Calvo F. Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br.J Cancer. 1992; 66: 623-628.
38. Bogin L, Papa MZ, Polak-Charcon S, Degani H. TNF induced modulations of phospholipid metabolism in human breast cancer cells. Biochim Biophys Acta 1998, 1392: 217-232
39. Ramírez deMolina A, Gutiérrez R, Ramos MA, Silva JM, Silva J, Bonilla F, Sánchez JJ, Lacal JC. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 2002; 21: 4317-4322.
40. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Morishita Y. Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer. Jpn J Cancer Res. 1999; 90: 1212-1217.
41. Mackinnon WB, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford CE. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy. Int J Cancer. 1994; 59: 248-261.
42. Mackinnon WB, May GL, Mountford CE. Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. Eur J Biochem. 1992; 205: 827-839.
43. Andrew ER, Bradbury A, Eades RG. Removal of dipolar broadening of nuclear magnetic spectra of solids by specimen rotation. Nature 1959; 183: 1802-1803.
44. Andrew ER. The narrowing of NMR spectra of solids by highspeed specimen rotation and the resolution of chemical shift and spin multiplet structures for solids. Prog NMR Spectrosc. 1971; 8: 1-39.
45. Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad IS. High resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
46. Aue WP, Karhan J, Ernst RR. Homonuclear broadband decoupling in two dimensional J-resolved NMR spectroscopy. J Chem Phys. 1976; 64: 4226-4227.
47. Ryner LN, Sorenson JA, Thomas MA. 3-D localized 2D-NMR spectroscopy on an MRI scanner. J Magn Reson. 1995; B107: 126-137.
48. 1H MR spectroscopy. strong coupling effects in vitro and in vivo. Magn Reson Imaging 1995; 13: 853-869.
49. Thomas MA, Hattori N, Umeda M, Sawada T, Naruse S. Evaluation of two-dimensional L-COSY and JPRESS using a 3T MRI scanner. From Phantoms to human brain in vivo. NMR Blomed. 2003; 16: 245-251.
50. 1H MR spectroscopy of human brain tumors in vivo. J. Magn Reson Imaging 1996, 6: 453-459.
51. Hurd RE, Gurr D, Sailasuta P. Proton spectroscopy without water suppression: the oversampled J-resolved experiment Magn Reson Med. 1998; 40: 343-347.
52. Schulte RF, Boesiger P. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed. 2006, 19: 255-263.
53. Provencher SW. Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra. Magn Reson Med. 1993; 30: 672-679.
54. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 1989; 9: 79-93.
55. 1H MR spectroscopy. J Magn Reson. 1994, 104: 1-10.
56. Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med. 2001; 46: 58-67.
57. 1H spectroscopy: validation in vivo. Am J Physiol. 1999; 276: E977-E989.
58. 1H MR spectroscopy. J Magn Reson Imaging. 1999; 10: 159-164.
59. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic reso nance imaging and proton, magnetic, resonance spectroscopy. BreastCancer Res Treat. 2001;68: 45-54.
60. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy: initial results. Radiology 2001; 220: 40-46.
61. Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJ, Vermeulen JW, Luyten PR. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 1988; 169: 615-620.
62. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998; 209: 269-275.
63. 1H-NMR detectable fatty acyl chain unsaturation in excised leimomyosarcoma correlate with grade and mitotic activity. J Clin Invest 1996, 98: 244-250.
64. Longmuir KJ. Phospholipid biosynthesis. In: Phospholipids Handbook, Cevc G (ed). Marcell Dekker: New York, 1993; 65-95.
65. Hietanen E, Punnonen K, Punnonen R, Auvinen O. Fatty acid composition of phospholipids and neutral lipids and lipid peroxidation in human breast cancer and lipoma tissue. Carcinogenesis. 1986; 7: 1965-1969.
66. De la Torre A, Debiton E, Durand D, Chardigny JM, Berdeaux O, Loreau O, Barthomeuf C, Bauchart D, Gruffat D. Conjugated linoleic acid isomers and their conjugated derivatives inhibit growth of human cancer cell lines. Anticancer Res. 2005; 25: 3943-3949.
67. Korman DB, Patapov SL. Breast cancer with low levels of blood lipids. Vopr Onkol. 1997; 43: 164-170.
68. Tsyrus' TP, Prokhorova VI, Derzhavets LA, Mashevski AA, Lisitsyn DM, Mashevskaia EA. Evaluation of the double bonds of lipid fatty acids by ozonization in cancer patients. Klin Lab Diagn. 2006; 6: 41-43.
69. Korman DB, Potapov SL, Shamaev VI, Pal'mina NP, Burlakova EB. The effect of chemotherapy on the total unsaturation and composition of plasma phospholipids and erythrocytes in patients with disseminated breast cancer. Izv Akad Nauk SSSR Biol. 1992; 2: 206-214.
70. Akinyanju PA, Akinyanju CO. Plasma and red cell lipids in sickle cell disease. Ann Clin Lab Sci. 1976; 6: 521-524.
71. Tan WC, Chapman C, Takatori T, Privett OS. Studies of lipid class and fatty acid profiles of rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Lipids. 1975; 10: 70-74.
72. Kwee IL, Nakada T, Ellis WG. Elevation in relative levels of brain membrane unsaturated fatty acids in Alzheimer's disease: high resolution proton spectroscopic studies of membrane lipid extracts. Magn Reson Med. 1991; 21: 49-54.
73. Kwok CT, Austin L. Phospholipid composition and metabolism in mouse muscular dystrophy. Biochem J. 1978; 176: 15-22.
74. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003; 49: 417-423.
75. Thomas EL, Hamilton G, Patel N, O'Dwyer R, Doré CJ, Goldin RD, Bell JD, Taylor-Robinson SD. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton spectroscopic study. Gut 2005; 54: 122-127.
76. Rutter A, Mackinnon WB, Huschtscha LI, Mountford CE. A proton magnetic resonance spectroscopy study of aging and transformed human fibroblasts. Exp Gerontol. 1966; 31: 669-686.
77. Beaumelle BD, Vial HJ. Modification of the fatty acid composition of individual phospholipids and neutral lipids after infection of the simian erythrocyte by Plasmodium knowlesi. Biochim Biophys Acta 1986; 877: 262-270.
78. Katz-Brull R, Rofsky NM, Morrin MM, Pedrosa I, George DJ, Michaelson MD, Marquis RP, Maril M, Noguera C, Lenkinski RE. Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy. Am J Physiol Renal Physiol. 2005; 288: F637-F641.
79. Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol. 2006; 100: 609-614.
80. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci. 2002; 967: 183-195.
81. Warensjo E, Riserus U, Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005; 48: 1999-2005.
82. Eitel K, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, Häring HU, Kellerer M. Different role of saturated and unsaturated fatty acids in β-cell apoptosis. Biochem Biophys Res Commun. 2002; 299: 853-856.
83. Velan SS, Durst C, Lemieux SK, Raylman RR, Sridhar R, Spencer RG, Hobbs GR, Thomas MA. Investigation of muscle lipid metabolism by localized one- and two-dimensional MRS techniques using a clinical 3T MRI/MRS scanner. J Magn Reson Imaging. 2007; 25(1): 192-199.
84. 1H NMR spectroscopy and self-organizing maps. NMR Biomed. 2003; 16: 1-11.
85. Chao CK, Pomfret EA, Zeisel SH. Uptake of choline by rat mammary- gland epithelial cells. Biochem J. 1988; 254: 33-38.
86. Ronen SM, Leach MO. Imaging biochemistry: applications to breast cancer. Breast Cancer Res. 2001; 3: 36-40.
87. Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, Russell P, Barraclough B, Gillett D, Himmelreich U, Dolenko B, Nikulin AE, Smith IC. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg. 2001; 88: 1234-1240.
88. Steinberg D, Colla P. CART: Classification and Regression Trees. Salford Systems: San Diego, 1997.
89. Sachs L. Applied Statistics: A Handbook of Techniques. Springer-Verlag: New York, 1982.
90. Morrison DF. Multivariate Statistical Methods, 3rd edn. McGraw-Hill: New York, 1990.
91. Abe H, Ashizawa K, Katsuragawa S, MacMahon H, Doi K. Use of an artificial neural network to determine the diagnostic value of specific clinical and radiologic parameters in the diagnosis of interstitial lung disease on chest radiographs. Acad Radiol. 2002; 9: 13-17.
92. Aoyama M, Li Q, Katsuragawa S, MacMahon H, Doi K. Automated computerized scheme for distinction between benign and malignant solitary pulmonary nodules on chest images. Med Phys. 2002; 29: 701-708.
93. Ashizawa K, Ishida T, MacMahon H, Vyborny CJ, Katsuragawa S, Doi K. Artificial neural networks in chest radiography: application to the differential diagnosis of interstitial lung disease. Acad Radiol. 1999; 6: 2-9.
94. van Ginneken B, Katsuragawa S, ter Haar Romeny BM, Doi K, Viergever MA. Automatic detection of abnormalities in chest radiographs using local texture analysis. IEEE Trans Med Imaging. 2002; 21: 139-149.
95. Eng J. Predicting the presence of acute pulmonary embolism: a comparative analysis of the artificial neural network, logistic regression, and threshold models. AJR Am J Roentgenol. 2002; 179: 869-874.
96. Nakamura K, Yoshida H, Engelmann R, MacMahon H, Katsuragawa S, Ishida T, Ashizawa K, Doi K. Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artificial neural networks. Radiology 2000; 214: 823-830.
97. McNitt-Gray MF, Hart EM, Wyckoff N, Sayre JW, Goldin JG, Aberle DR. A pattern classification approach to characterizing solitary pulmonary nodules imaged on high resolution CT: preliminary results. Med Phys. 1999; 26: 880-888.
98. Mountford C, Lean C, Malycha P, Russell P. Proton Spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imag. 2006; 24: 459-477.
99. Mayer D, Kim DH, Adalsteinsson E, Spielman DM. Fast CT-PRESS-based spiral chemical shift imaging at 3 Tesla. Magn Reson Med 2006; 55: 974-978.
100. Delikatny EJ, Hull WE, Mountford CE. The effect of altering time domains and window functions in two-dimensional proton COSY spectra of biological specimens. J Magn Reson. 1991; 94: 563-573.